The gradual loss of renal function related to cardiometabolic decline is the body’s response to inflammation, high blood pressure, obesity, tobacco and alcohol use, uncontrolled blood glucose, and other acquired (noncongenital) and lifestyle factors. Therapeutic options to preserve kidney function can slow disease progression and reduce burden.
Because Cardiometabolic Health Conference (CMHC) is committed to keeping busy providers well-informed on the most current developments affecting their practice, this week’s Pulse Blog focuses
Potassium-rich foods like bananas, avocados, tomatoes, and squash are generally regarded as healthful, especially for lowering blood pressure and improving cardiovascular health. However, patients with
Cardiometabolic Disease
Cardiometabolic Disease
Chronic Kidney Disease
Atherosclerosis/Thrombosis
Watch the experts share some highlights including:
New and ongoing studies with novel non-steroidal MRAs in addressing cardiorenal risk, including in patients with heart failure and in those with non-diabetic kidney disease.Â
Watch the experts share some highlights including:
Watch the experts share some highlights including:
Watch the experts share some highlights including:
Watch the experts share some highlights including:
Challenges and Advances in Diabetic Kidney Disease - coverage from a 2021 Annual Symposium
The Challenge of Slowing Diabetic Kidney Disease Progression and Reducing Cardiovascular Risk: Recent Advances and Novel Strategies
Watch Now
Read More >
Read More >
CKD = chronic kidney disease; ESKD = end-stage kidney disease; HIF-PH = hypoxia-inducible factor prolyl hydroxylase; type 2 diabetes
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
Cardiometabolic Health Congress
1801 N Military Trail, Ste 110
Boca Raton, FL, 33431
Copyright © 2023, Cardiometabolic Health Congress. All Rights Reserved.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
